Costa A - Search Results

1

CA 15.3 as a signal of undetectable breast cancer metastases in a follow-up period of 4 years.

Pizzichetta M, Bogni A, Seregni E, Maffioli L, de Jager E, Costa A, Bombardieri E. Pizzichetta M, et al. Among authors: costa a. Int J Biol Markers. 1992 Jan-Mar;7(1):59-60. doi: 10.1177/172460089200700109. Int J Biol Markers. 1992. PMID: 1583349 No abstract available.

2

Lack of correlation between plasmatic levels of retinol and RBP and thyroid hormones in breast cancer patients treated with the synthetic retinoid fenretinide.

Pizzichetta M, Formelli F, Bombardieri E, Bruni GF, Costa A. Pizzichetta M, et al. Among authors: costa a. Int J Biol Markers. 1990 Oct-Dec;5(4):208. doi: 10.1177/172460089000500409. Int J Biol Markers. 1990. PMID: 2151235 No abstract available.

3

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases.

Bombardieri E, Pizzichetta M, Veronesi P, Seregni E, Bogni A, Maffioli L, Jotti GS, Bassetto MA, Zurrida S, Costa A. Bombardieri E, et al. Among authors: costa a. Eur J Cancer. 1992;29A(1):144-6. doi: 10.1016/0959-8049(93)90595-7. Eur J Cancer. 1992. PMID: 1445733

4

Chest x-ray survey in breast cancer follow-up--a contrary view.

Andreoli C, Buranelli F, Campa T, Costa A, Magni A, Pizzichetta M, Ciatto S. Andreoli C, et al. Among authors: costa a. Tumori. 1987 Oct 31;73(5):463-5. doi: 10.1177/030089168707300506. Tumori. 1987. PMID: 3686679

5

Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.

Formelli F, Carsana R, Costa A, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M. Formelli F, et al. Among authors: costa a. Cancer Res. 1989 Nov 1;49(21):6149-52. Cancer Res. 1989. PMID: 2529028 Clinical Trial.

6

The synthetic retinoid fenretinide does not affect circulating hormone concentrations.

Secreto G, Costa A, Recchiane C, Pizzichetta M, Ballerini P. Secreto G, et al. Among authors: costa a. Breast Cancer Res Treat. 1988 Dec;12(3):315-6. doi: 10.1007/BF01811246. Breast Cancer Res Treat. 1988. PMID: 2976280 Clinical Trial. No abstract available.

7

Cell kinetics of hepatic metastases as a prognostic marker in patients with advanced colorectal carcinoma.

Silvestrini R, Costa A, Gennari L, Doci R, Bombardieri E, Bombelli L. Silvestrini R, et al. Among authors: costa a. HPB Surg. 1990 Apr;2(2):135-43; discussion 143-4. doi: 10.1155/1990/12854. HPB Surg. 1990. PMID: 2278908 Free PMC article.

8

Tolerability of the synthetic retinoid Fenretinide (HPR).

Costa A, Malone W, Perloff M, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M, Andreoli C, Del Vecchio M, et al. Costa A, et al. Eur J Cancer Clin Oncol. 1989 May;25(5):805-8. doi: 10.1016/0277-5379(89)90124-7. Eur J Cancer Clin Oncol. 1989. PMID: 2525470 Clinical Trial.

9

Psychologic aspects of patients participating in a phase I study with the synthetic retinoid 4-hydroxyphenyl retinamide.

Filiberti A, Tamburini M, Andreoli C, Buranelli F, Campa T, Costa A, Dossena G, Magni A, Pizzichetta M, Ventafridda V. Filiberti A, et al. Among authors: costa a. Tumori. 1988 Jun 30;74(3):353-6. doi: 10.1177/030089168807400319. Tumori. 1988. PMID: 2969638 Clinical Trial.

10

Rationale for a study adding tamoxifen to HRT.

Rotmensz N, Decensi A, Maisonneuve P, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Lovison F, Gucciardo G, Muraca MG, Pizzichetta MA, Conforti S, Robertson C, Boyle P, Veronesi U. Rotmensz N, et al. Among authors: costa a. Eur J Cancer. 2002 Nov;38 Suppl 6:S22-3. doi: 10.1016/s0959-8049(02)00272-1. Eur J Cancer. 2002. PMID: 12409061 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,809 results

Search Page

Filters